TEVA 3145 (Cephalexin monohydrate 250 mg)

Pill imprint TEVA 3145 has been identified as Cephalexin monohydrate 250 mg.

Cephalexin is used in the treatment of skin or soft tissue infection; bacterial infection; bladder infection; upper respiratory tract infection; acne (and more), and belongs to the drug class first generation cephalosporins. There is no proven risk in humans during pregnancy. Cephalexin 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Cephalexin monohydrate

Imprint:

TEVA 3145

Strength:

250 mg

Color:

Gray / Orange

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

First generation cephalosporins

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Teva Pharmaceuticals USA

National Drug Code (NDC):

00093-3145

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.